Quantum-Guided Gene Editing in a Life-Saving Bone Marrow Transplant: A Highlight from CRISPRMED25

A case study presented at CRISPRMED25 shows how quantum biosensors monitored prime editing to correct a sickle cell mutation in donor bone marrow cells, enabling a successful transplant for an acute myeloid leukemia patient.

By: Ms. Asra Hamidi, for BioQuick News - Apr. 11, 2025

One of the most technically notable presentations at the 2^nd Annual CRISPR* Medicine 2025 Conference (CRISPRMED25) in Copenhagen was a poster titled “Quantum-Enhanced Precision and Real-Time Monitoring of Prime Editing in Bone Marrow Transplantation for AML,” led by Dr. Sunil Joshi, Founder and CEO of Quantum Immunogenix – A Third Eye Network INC (USA).

This poster detailed a real-world case in which gene-editing and quantum-sensing technologies were used to enable a successful bone marrow transplant in a highly complex clinical scenario. The patient involved was diagnosed with acute myeloid leukemia (AML) and urgently required a bone marrow transplant. However, the only available HLA-compatible donor had sickle cell disease—a condition that introduces significant genetic risk to the transplant.

To overcome this, the research team employed Prime Editing to correct the β-globin gene mutation responsible for sickle cell anemia in the donor’s hematopoietic stem cells.

Read the full article at BioQuick News here.

BioQuick® Online News LLC is dedicated to the timely reporting of key life science and medical advances from around the globe. BioQuick has readers in over 160 countries. BioQuick also has a Japanese-language edition. BioQuick has received prestigious APEX Awards for Publishing Excellence in nine consecutive years. BioQuick currently offers over 8,000 articles on major life science and medical advances of the last ten years, and a total of over 1,000,000 page views in that time. A particular topic can be easily looked for using the publication’s powerful search engine. Recently, BioQuick has been a media partner for a number of major scientific events, including the CRISPR Medicine Conference 2025 and the Precision Medicine World Conference (PMWC) Annual Meeting 2025. BioQuick is actively seeking additional advertising and sponsorship. Mike O’Neill, a long-time award-winning science writer, is the editor & publisher of BioQuick.

To get more CRISPR Medicine News delivered to your inbox, sign up to the free weekly CMN Newsletter here.

ArticleBioQuick NewsNewsCRISPRMED25